Come up with a name for your new list and we'll add to it:
Riparian Pharmaceuticals raised a round of funding on December 21, 2016. Investors include
Harvard Life Lab.
Riparian Pharmaceuticals is exploring therapeutics that would modify the biology within blood vessel walls to help with cardiovascular, diabetic, and kidney diseases.…